September 26, 2017
BioLineRx Announces Initiation of Phase 1b/2 Trial for BL-8040 in AML Under Immunotherapy Collaboration
September 7, 2017
BioLineRx to Present at the 19th Annual Rodman & Renshaw Global Investment Conference in New York
August 21, 2017
BioLineRx Announces Regulatory Submission of Phase 3 Registrational Study for BL-8040 in Stem Cell Mobilization
August 8, 2017
BioLineRx Reports Second Quarter 2017 Financial Results